Sorry, this entry is only available in Polish.
Powiązane
SK&S recommended in IFLR1000 – 2024
We have been recommended in the IFLR1000 ranking! At the same time, we have received recognition for the exceptional work…
25 Oct 2024
SK&S advised owners of El-Cab sp. z o.o on sale of a controlling stake to American corporation Amphenol
The Sołtysiński Kawecki & Szlęzak law office provided advice to owners of El-Cab sp. z o.o on the sale of…
11 Mar 2021
SK&S advised the Unilin group, part of the Mohawk Group, on the acquisition of shares in a subsidiary of LENTEX S.A.
SK&S’ transaction team advised the Unilin group, part of the US-based Mohawk Group, in its acquisition of a 100% stake…
24 Nov 2022
SK&S recommended in IFLR1000
We are pleased to announce that the law firm SK&S, as well as our expert attorneys, have been once again…
08 Sep 2022
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
SK&S advised Heineken International B.V. on the acquisition of the shares in Grupa Żywiec S.A.
SK&S advised Heineken International B.V. in connection with its approx. PLN 1.66 billion (approx. EUR 347 million) acquisition of the…
26 Jan 2023
SK&S recommended in the Legal500 ranking – 2024
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
28 Mar 2024
SK&S recommended in IFLR1000
We are pleased to announce that IFLR1000 ranking recommended us in the following categories: Banking M&A Project finance Project development:…
18 Sep 2023
SK&S recommended in the Legal500 ranking – 2022
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
12 Apr 2022
SK&S Advised Velocity Clinical Research on the acquisition of KO-MED Clinical Centers
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
14 Feb 2024
